Virtu Financial LLC Moleculin Biotech, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.9 - $1.34 $2,468 - $3,675	2,743 Added 19.89%	16,534 $16,000
Q4 2022 Feb 15, 2023	BUY	$0.85 - $1.49 $11,722 - $20,548	13,791 New	13,791 $15,000
Q1 2022 May 17, 2022	SELL	$1.23 - $1.9 $57,375 - $88,629	-46,647 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.64 - $2.83 $76,501 - $132,011	46,647 New	46,647 $87,000
Q3 2021 Nov 12, 2021	SELL	$2.7 - $3.59 $68,315 - $90,834	-25,302 Closed	0 $0

Q2 2021 Sep 17, 2021	BUY	$3.21 - $4.06 $81,219 - $102,726	25,302 New	25,302 $93,000

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $124M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.